Balanced news tone
News Sentiment
VIVIMEDLAB sentiment intelligence
Vivimed Labs Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
86/100 classification confidence.
directly relevant articles
high-authority source matches
-6.6% over one week, -11.6% over four weeks, trend inactive, and near fair-value range.
Vivimed Labs postpones board meeting for FY26 results
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Vivimed Labs postpones board meeting for FY26 results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 May 2026 07:00
- Source
- scanx.trade
Vivimed Labs Limited Enters Corporate Insolvency Resolution Process
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Apr 2026 07:00
- Source
- scanx.trade
Vivimed Labs Limited Insolvency Process: CIRP Commences 15.04.2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- scanx.trade
Vivimed Labs Reports Widened Q3 FY26 Loss at ₹165.66 Million on Lower Revenue
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 13 Mar 2026 07:00
- Source
- scanx.trade
Vivimed Labs Secures High Court Interim Stay on CBI Case and Bank Fraud Declaration
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 15 Feb 2026 08:00
- Source
- scanx.trade
Vivimed Labs Limited's (NSE:VIVIMEDLAB) 31% Dip In Price Shows Sentiment Is Matching Revenues
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Feb 2026 08:00
- Source
- simplywall.st
Vivimed Labs Secures High Court Stay on CBI Proceedings After Search Operations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Feb 2026 08:00
- Source
- scanx.trade
Vivimed Labs Limited Trading Suspension Revoked by BSE and NSE, Trading to Resume December 18
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Dec 2025 08:00
- Source
- scanx.trade
Vivimed Labs Ltd. Share Price Today | Vivimed Labs Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Mar 2022 11:06
- Source
- Value Research
Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in India
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 May 2021 07:00
- Source
- The Economic Times
Vivimed Labs share price up nearly 5% on approval of products
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 13 Oct 2020 07:00
- Source
- Moneycontrol.com
Vivimed Labs Did Not Disclose Transfer and Sale of Business Units, Twice
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Sep 2019 07:00
- Source
- Moneylife
OrbiMed invests $42.5 mn in Vivimed’s bulk-drugs unit
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Sep 2017 07:00
- Source
- VCCircle
Clariant to acquire a part of Vivimed Labs' personal care portfolio
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Oct 2015 07:00
- Source
- Business Standard
Vivimed sells part of specialty chemical unit for $57.7M
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Sep 2015 07:00
- Source
- VCCircle
PE-backed Vivimed buys Hyderabad-based Finoso Pharma for $2.8M
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Feb 2013 08:00
- Source
- VCCircle